To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

April 29, 2024

Know All Your Treatment Options: FREE Registration Open Now

EBCI's Know All Your Treatment Options (KAYTO) 2024
May 17, 2024 | 11AM - 2PM PT | Online

KAYTO 2021 logo
Gamma Tile Official Logo - 2024
KiyateclogovBRIGHT 1920w.jpg 1

This free patient disease education webinar, produced and moderated by the End Brain Cancer Initiative (EBCI), is designed specifically for members of the brain tumor, brain cancer, and metastasized brain tumor community, including Health Care Providers. Hear directly from and have direct access to specialists in this field about treatment options, clinical trials, devices, and diagnostics that you may not have heard about.

Venur Vyshak 0
fred hutch logo e1712704466110

Dr. Vyshak Venur is a member of EBCI's Medical Advisory Board and an Oncologist, Co-Director for Clinical Research, Assistant Professor, and Clinical Director for Neuro-oncology at Fred Hutchinson Cancer Center.

At EBCI's Know All Your Treatment Options free webinar on May 17, he will be speaking about Vorasidenib. If FDA approved, the drug Vorasidenib would be the first FDA-approved drug specifically for Low Grade Gliomas (LGG) in adults.

This exciting development could save lives by potentially preventing Low Grade Gliomas from turning into High Grade Gliomas.

Register below to hear the presentations from Dr. Vyshak Venur and other specialists, plus get the opportunity to ask your questions. We look forward to having you join us at 11AM PT on Friday, May 17th!

EBCI Happy cancer patient woman with hat e1665030951309

GiveBIG24 Solid

Your gift to the End Brain Cancer Initiative (EBCI) for GiveBIG will help patients and families facing brain cancer, brain tumors, and metastatic disease to the brain by helping us provide free DIRECT support, a wealth of free online resources, and ongoing advocacy for increased patient access to specialists, advanced treatments, and devices

With the help of individual supporters like you, we were able to make a big impact in 2023. EBCI reached nearly 17 million people in 2023 through our online resources, free one-to-one “DIRECT CONNECT” services for patients and families, and disease education outreach initiatives. You can help provide much-needed support, guidance, and access to potentially life-saving treatments and resources for this underserved patient population.

Help us reach our goal of $20,000 dollars raised by May 8th, 2024!

Sponsor logos

Hand holding cell phone displaying app

MORE Meetings, Events, Disease Education Education and Resources


Scan or click the QR code to download the App now!


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram